Πέμπτη, 25 Νοεμβρίου 2021 16:25

Ανακοινωση ομιλίας - Νευροεπιστήμες, διαδικτυακά

Προστέθηκε από την 

Ελαβα και σας προωθώ για τυχόν ενδιαφερόμενα άτομα

Seminar Announcement

To facilitate the organization of the seminar presented below please register using the link https://us02web.zoom.us/meeting/register/tZYvcu-prjIpGtU1MAW6-6X8FwwTR3bI6P0F

The Hellenic Initiative against Alzheimer’s Disease (HIAAD) and the Athens International Master’s Programme in Neurosciences invite you to attend a seminar by Professor Roger Nitsch (University of Zurich, https://www.uzh.ch/en.html) and CEO of Neurimmune (www.neurimmune.com)

The title of the seminar is: "Development of monoclonal antibodies targeting amyloid beta for the potential treatment of Alzheimer’s disease”

Roger M Nitsch serves as CEO & President of Neurimmune. A neuroscientist with a background in medicine, Roger is recognized as a key opinion leader in neurodegenerative diseases with more than 30 years of experience in Alzheimer’s disease research, and as a pioneer in the development of therapeutic approaches for neurodegenerative diseases. The Potamkin prize winner and Member of the German Academy of Sciences served as a founding director of the Institute for Regenerative Medicine (IREM), University of Zurich where he holds a part-time professorship teaching bio-entrepreneurship. Roger founded Neurimmune in 2006 together with Jan Grimm and Christoph Hock.

Date and Time: December 2nd, 2021, 4 pm Greek time

To attend and register, please, using the link:

https://us02web.zoom.us/meeting/register/tZYvcu-prjIpGtU1MAW6-6X8FwwTR3bI6P0F

Meeting ID: 822 5610 9301, Passcode: 021221

Διαβάστηκε 225 φορές